Ganirelix and the prevention of premature luteinizing hormone surges

Ganirelix and the prevention of premature luteinizing hormone surges

Ganirelix is a gonadotropin-releasing hormone (GnRH) antagonist with high antagonistic activity that blocks the GnRH receptor by competitive binding. A daily dose of 0.25 mg of ganirelix was sel5ected after a phase II study because it was the minimal, effective daily dose to prevent premature lutein...

Full description

Bibliographic Details
Main Author:	Bernadette Mannaerts, Ph.D.
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	F&S Reports
Subjects:	GnRH antagonist pregnancy rates OHSS prevention of premature LH surges ganirelix
Online Access:	http://www.sciencedirect.com/science/article/pii/S266633412300017X

Similar Items

Successful outcome of a pregnancy derived from premature ovulation in a gonadotropin‐releasing hormone antagonist protocol: A case report
by: Daichi Inoue, et al.
Published: (2021-02-01)

Dose-finding study of Leuplin depot for prevention of premature luteinizing hormone surge during controlled ovarian stimulation: a pilot study in intrauterine insemination treatment
by: Heng-Ju Chen, et al.
Published: (2016-04-01)

Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial
by: Yun Wang, et al.
Published: (2018-08-01)

Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval
by: Tzu-Ching Kao, et al.
Published: (2023-01-01)

The role of elagolix in the suppression of ovulation in donor oocyte cycles
by: Catherine Boniface, M.D., et al.
Published: (2023-06-01)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
by: Qiuju Chen, et al.
Published: (2019-11-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2016-05-01)

New local ganirelix sustained release therapy for uterine leiomyoma. Evaluation in a preclinical organ model
by: Ana Salas, et al.
Published: (2022-12-01)

A STUDY ON THE EFFECTIVENESS OF CLOMIPHENE CITRATE IN COMPARISON TO GNRH ANTAGONIST IN PREVENTING LH SURGE AMONG PATIENTS UNDERGOING OVULATION INDUCTION IN IVF-ICSI
by: Shiuan Yee Tan, et al.
Published: (2018-08-01)

Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
by: Dan Zhang, et al.
Published: (2018-12-01)

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
by: Shen Zhao, et al.
Published: (2023-01-01)

The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
by: Cornelis B. Lambalk, M.D., Ph.D.
Published: (2023-06-01)

Impact of different controlled ovarian stimulation protocols on the physical and psychological burdens in women undergoing in vitro fertilization/intra cytoplasmic sperm injection
by: Deenadayal Mamata, et al.
Published: (2015-01-01)

Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
by: Jamie Merkison, et al.
Published: (2022-09-01)

A Premature Rise of Luteinizing Hormone Is Associated With a Reduced Cumulative Live Birth Rate in Patients ≥37 Years Old Undergoing GnRH Antagonist In Vitro Fertilization Cycles
by: Fumei Gao, et al.
Published: (2021-12-01)

Self-Detection of the LH Surge in Urine After GnRH Agonist Trigger in IVF—How to Minimize Failure to Retrieve Oocytes
by: Mauro Cozzolino, et al.
Published: (2020-04-01)

Prevention of Ovarian Hyper stimulation Syndrome by using gonadotrophic releasing hormone analogue to induce final ovulation trigger in invitro fertilization cycles
by: Safia Sultana, et al.
Published: (2023-04-01)

The value of LH maximum level in predicting optimal oocyte yield following GnRH agonist trigger
by: William Hao-Yu Lee, et al.
Published: (2023-08-01)

Dose-Dependent Chlormadinone Acetate Can Suppress Premature LH Surge in Parallel with LH Value Reduction
by: Yuya Takeshige, et al.
Published: (2020-03-01)

A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study protocol for a randomized controlled, non-inferiority trial
by: Shan Liu, et al.
Published: (2022-08-01)

Effect of CD14/TLR4 antagonist on GnRH/LH secretion in ewe during central inflammation induced by intracerebroventricular administration of LPS
by: Karolina Haziak, et al.
Published: (2018-07-01)

Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01)

Circadian Control of the Estrogenic Circuits Regulating GnRH Secretion and the Preovulatory Luteinizing Hormone Surge
by: Lance J Kriegsfeld, et al.
Published: (2012-05-01)

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01)

Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01)

Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
by: Fabrizio Fontana, et al.
Published: (2020-12-01)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
by: Depeng Zhao, et al.
Published: (2023-01-01)

Prenatal androgen treatment impairs the suprachiasmatic nucleus arginine-vasopressin to kisspeptin neuron circuit in female mice
by: Bradley B. Jamieson, et al.
Published: (2022-08-01)

The role of GABA in the regulation of GnRH neurons
by: Miho eWatanabe, et al.
Published: (2014-11-01)

Pulsatile gonadotropin-releasing hormone: clinical applications of a physiologic paradigmEssential Points
by: Marco Filicori, M.D.
Published: (2023-06-01)

Chemogenetic Depletion of Hypophysiotropic GnRH Neurons Does Not Affect Fertility in Mature Female Zebrafish
by: Sakura Tanaka, et al.
Published: (2022-05-01)

Troxerutin protects against DHT-induced polycystic ovary syndrome in rats
by: Zixuan Gao, et al.
Published: (2020-09-01)

GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile
by: Nirja Chaudhari, et al.
Published: (2018-04-01)

Indução da ovulação em cabras, fora da estação reprodutiva, com LH e GnRH e com estro induzido por progestágenos Induction of the out-of-season ovulation (with LH and GnRH) and estrus (with progesterone) in goats
by: P.A.G. Leite, et al.
Published: (2006-06-01)

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
by: Johnny S. Younis, et al.
Published: (2017-10-01)

LH level on the antagonist administration day as a predictor of the reproductive outcomes in women with normal ovarian function
by: Conghui Pang, et al.
Published: (2023-09-01)

Protocol shift from agonist to antagonist or vice versa after an unsuccessful intracytoplasmic sperm injection cycle on the same patient does not improve outcome
by: Yavuz Emre Şükür, et al.
Published: (2018-06-01)

Does Basal Morning Luteinizing Hormone (bLH) Predict Central Precocious Puberty (CPP) in Girls?
by: Federico Baronio, et al.
Published: (2024-03-01)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
by: Kristof Chwalisz, M.D., Ph.D.
Published: (2023-06-01)